The Fortrea Podcast
The Fortrea Podcast
Ophthalmology Perspectives | Ep 3 | Gene Therapy, Patient-Centric Operations, and Risk-Benefit Challenges in Phase 1 Ophthalmology Trials
•
Marina
•
Season 10
•
Episode 3
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Today we explore the unique challenges and opportunities in Phase 1 ophthalmology clinical trials, focusing on gene therapy and inherited retinal diseases.
Host: Amber Burg
Participants: David Hoelscher, Senior Medical Director, Ophthalmology
Tanya Richardson, Therapeutic Strategy Head, Ophthalmology and Neuroscience